Cognitive therapy for bipolar affective disorder David S. Janowsky Clinical Trials Report Pages: 439 - 439
Lamotrigine and topiramate for bipolar affective disorder David S. Janowsky Clinical Trials Report Pages: 440 - 441
Olanzapine and risperidol for bipolar affective disorder David S. Janowsky Clinical Trials Report Pages: 441 - 443
Introversion and extroversion: Implications for depression and suicidality David S. Janowsky OriginalPaper Pages: 444 - 450
Rapid cycling bipolar disease: New concepts and treatments Steven L. Dubovsky OriginalPaper Pages: 451 - 462
Current management of premenstrual syndrome and premenstrual dysphoric disorder Leslie BornMeir Steiner OriginalPaper Pages: 463 - 469
Depression and nicotine: Preclinical and clinical evidence for common mechanisms Rene P. LajeJoshua A. BermanAlexander H. Glassman OriginalPaper Pages: 470 - 474
3,4-methylenedioxymethamphetamine (mdma): A review Grace O’LearyJessica NargisoRoger D. Weiss ReviewPaper Pages: 477 - 483
Opioid antagonists in the treatment of alcohol dependence Grace O’LearyJennifer BorrowRoger D. Weiss OriginalPaper Pages: 484 - 488
Attention deficit hyperactivity disorder (ADHD) and substance use disorders Jeffrey J. WilsonFrances R. Levin OriginalPaper Pages: 497 - 506
Residual neuropsychologic effects of cannabis Harrison G. Pope Jr.Amanda J. GruberDeborah Yurgelun-Todd OriginalPaper Pages: 507 - 512
